Back
Alto Neuroscience, Inc. 10K Form
Sell
39
ANRO
Alto Neuroscience, Inc.
Last Price:
$13.43
Seasonality Move:
-30.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ANRO News And Ratings
See the #1 stock for the next 7 days that we like better than ANRO
ANRO Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-9.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.11 |
| Price / Book: | 3.74 |
Profitability
| EPS (TTM): | -2.30130 |
|---|---|
| Net Income (TTM): | $-62.3M |
| Gross Margin: | $-502K |
| Return on Equity: | -45.08% |
| Return on Assets: | -36.8% |
Alto Neuroscience, Inc. Earnings Forecast
Key Alto Neuroscience, Inc. Financial Ratios
-
Per Share Earnings over the last 4 years have been positive in 0 years.
Alto Neuroscience, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ANRO |
| Website: | altoneuroscience.com |
Debt
| Debt-to-Equity Ratio: | 0.25 |
|---|---|
| Current Ratio: | 15.42 |
| Quick Ratio: | 15.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ANRO Technical Analysis vs Fundamental Analysis
Sell
39
Alto Neuroscience, Inc. (ANRO)
is a Sell
Is Alto Neuroscience, Inc. a Buy or a Sell?
-
Alto Neuroscience, Inc. stock is rated a SellThe current Alto Neuroscience, Inc. [ANRO] share price is $13.43. The Score for ANRO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.